Sunstein Insights Shape Created with Sketch.

Filter Results

Showing publications by Bruce D. Sunstein. View Bruce's Full Profile

  1. Why due diligence is not a rear guard action for the patent-savvy company in a patent deal
  2. Strategies for Pharmaceutical Portfolio & Product Life-Cycle Management In Face of the New U.S. Patent Law
  3. Supreme Court Invalidates Diagnostic Claims; Its Reasoning Promises Broad Implications
  4. America Invents Act: Highlights of First-to-File
  5. Congress Brings First-to-File Patent System to the U.S.
  6. Disembodied Embodiments: Medical Device Strategy for PCT and Foreign Applications
  7. Change Is in the Air: Be Ready for a First-To-File Patent System
  8. Five-lecture series at Korea Advanced Institute of Science and Technology
  9. Updated Guidelines on What Is “Obvious” Reflect an Updated PTO
  10. Strategic Implications for Pharmaceuticals in Recent U.S. Patent Law Developments
  11. What Kind of Patent Portfolios Will Matter to Life Science Companies in the Next Five Years
  12. Federal Judge Would Invalidate All DNA Patents, But His Rationale Is Controversial

Knowledge Charts

  • Flowchart for determining when U.S. Copyrights in fixed works expire View flowchart
  • Inter Partes Review flowchart charting key dates and milestones View flowchart

We use cookies to improve your site experience, distinguish you from other users and support the marketing of our services. These cookies may store your personal information. By continuing to use our website, you agree to the storing of cookies on your device. For more information, please visit our Privacy Notice.

Subscribe to our Newsletters

Subscribe to: